2026-10-25
ESCO Technologies clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,906 −5.38%
S&P 7,400 −3.75%
GOLD $4,127 +1.33%
BTC $76,159 −5.28%
VIX 24.13 +45.27%
latest tape · as of 20:03 UTC
The Screen · Technology · Scientific & Technical Instruments
ESCO Technologies Inc.
ESE · the NYSE · USD · Market cap $6.2B · 3,359 employees
ESCO Technologies Inc.
Not yet scored239.86 USD
Price as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price239.86 USD at the 4 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 4 Nov 2026
- Our regime readDistribution, as of 4 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans to puts (put/call 3.14)
- Last reviewed4 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $293.64 to $337.69, base estimate $293.64 (screen dated 2026-11-04).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 3.14, read 2026-11-05
- Ethical screen not yet scored
Price239.86 USD
Fair value293.64
Ethical score70.0/100
Value readUndervaluedas of 4 Nov 2026
Our investment reviews on this name
2026-10-28Read Distribution247.64-3.1% to today ✓Markdown gives way to Distribution after an 8% slide in 4 weeks
2026-10-02Read Markdown269.92-11.1% to today ✓Distribution gives way to Markdown after a 14% slide in 13 weeks
2026-07-02Read Distribution313.74-23.5% to today ✓First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its distribution label.
ESCO Technologies Inc. holds its Distribution at $239.86. The statistical read favours the sellers, held for 39 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 39 days |
| Price at the screen | $239.86 |
| Valuation | 44.50 trailing · 26.01 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.05 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 9.56% | Below 33% | Interest-bearing debt is just 9.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 14.72% | Below 49% | Money owed to the company is 14.7% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
ESCO Technologies clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
ESCO Technologies clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 10%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 4 Nov 2026: it trades at roughly an 18% discount to our $293.64 fair value, 14.40% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 18.3% discount to the base estimate.
Third-party analyst targets. The average target sits +45% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $293.64, with a range of $293.64 to $337.69, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsDefence filters maker priced above its worth
Picture the quiet components keeping navy ships and jets running without leaks or failures. ESCO builds those filtration systems for aerospace and defence customers, and its revenue has jumped 34 percent while margins sit at a healthy 25 percent.
We pass because the shares trade at 35 times forward earnings with a negative margin of safety and a low 9 percent return on equity. The market already prices in strong growth, yet the numbers do not show enough value to offset the premium paid today.
High valuation leaves little room for any slowdown in defence spending or execution slips, even though the business clears our ethical screen. Analysis, not advice.
| Forward P/E | 26.0xpriced for continued growth |
| Trailing P/E | 44.5xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 5.39 |
| EPS, forward | 9.22 |
| Revenue growth | +14.4%steady growth |
| Profit margin | 24.4%healthy profit margins |
| Return on equity | 9.5%a modest return on shareholder capital |
| FCF yield | 3.76% |
| Dividend yield | 10.00% |
| Debt to equity | 0.09minimal debt: a conservative balance sheet |
| Current ratio | 1.38adequate liquidity, worth monitoring |
| Beta | 1.05moves a little more than the market |
| Short interest, float | 0.03% |
| 52-week range | 193.68 - 362.15 |
| Market cap | $6.2B |
| Employees | 3,359 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeESE trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-04
Distribution $250.59
+1.2% Entry 10
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.2% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (3 analysts) rates it none, with a mean price target of $373.
2026-10-28
Distribution · changed $247.64
+0.0% Entry 9
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (3 analysts) rates it none, with a mean price target of $373.
2026-10-21
Markdown $247.64
-4.0% Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (3 analysts) rates it none, with a mean price target of $373.
2026-10-14
Markdown $257.83
-4.5% Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (3 analysts) rates it none, with a mean price target of $373.
2026-10-02
Markdown · changed $269.92
-2.5% Entry 6
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (3 analysts) rates it none, with a mean price target of $373.
2026-08-28
Distribution $276.82
-13.1% Entry 5
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 13.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (3 analysts) rates it none, with a mean price target of $373.
2026-07-27
Distribution $318.52
+1.5% Entry 4
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (3 analysts) rates it none, with a mean price target of $373.
2026-07-18
Distribution $313.74
+0.0% Entry 3
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (3 analysts) rates it none, with a mean price target of $373.
2026-07-03
Distribution $313.74
+0.0% Entry 2
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02
Distribution $313.74
Entry 1
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 3 Defense Stocks to Watch Before the Pentagon Rare Earth Sourcing Shift Yahoo Finance · 11d ago
- ESCO Technologies Announces Fourth Quarter 2026 Earnings Release and Conference Call Yahoo Finance · 15d ago
- Will Esco Technologies (ESE) Beat Estimates Again in Its Next Earnings Report? Yahoo Finance · 16d ago
- 3 US Defense Stocks Riding Homeland Security Spending Growth Yahoo Finance · 20d ago
- 1 Cash-Producing Stock to Own for Decades and 2 We Question Yahoo Finance · 20d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
STSensata Technologies Holding plc
NOVTNovanta Inc.
VNTVontier Corporation
CGNXCognex Corp
BMIBadger Meter, Inc.
ITRIItron, Inc.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-10-15 | David Taylor | Republican | buy | 1K–15K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 15K–50K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 15K–50K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 15K–50K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 15K–50K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $297.85 | +2.6% | · | $1,026 | +2.6% |
| 2 months | $310.59 | -1.7% | · | $984 | -1.7% |
| 3 months | $266.36 | +14.7% | $0.08 | $1,147 | +14.7% |
| 6 months | $206.41 | +48.0% | $0.16 | $1,481 | +48.1% |
| 1 year | $183.83 | +66.2% | $0.32 | $1,663 | +66.3% |
| 2 years | $105.22 | +190.3% | $0.64 | $2,909 | +190.9% |
| 3 years | $96.04 | +218.1% | $0.96 | $3,191 | +219.1% |
| 5 years | $88.69 | +244.4% | $1.60 | $3,462 | +246.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ESE does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.